Doctors at Karl Landsteiner University of Health Sciences review data on immune reactions in heart muscle inflammation. Immunotherapy is a powerful weapon in the fight against cancer, but inflammation of the heart muscle (myocarditis) is one of its most serious side effects. This has been highlighted in a review article on the immunological causes and processes of myocarditis, which has just been published by an international research team. Autoimmune reactions are in fact among the most common causes of myocarditis. And such reactions can be triggered by cancer immunotherapies due to their specific modes of action. The increasing use of these treatments could therefore lead to an increase in cases of myocarditis.

Due to the special situation around COVID-19, the organizers of the Campus Ball Krems, Danube University Krems, IMC University of Applied Sciences Krems and Karl Landsteiner Private University for Health Sciences, have decided to cancel the ball planned for 27 June 2020.

The comparison of the bone structure of two early human finds in South Africa suggests, according to a study involving KL researchers, that the development from tree to terrestrial form of living and thus climbing to walking upright in early humans may not have been linear. This was demonstrated in a recently published study using the worldwide unique software to examine bone structure and density, developed by Professor Dieter Pahr, researcher at KL Krems and TU Vienna.

Current information about the Coronavirus and recommended measures by KL for students and staff can be read here.

Since Tuesday evening, the online platform www.kl.ac.at/coronavirus has been offering secure, up-to-date and well-founded recommendations for action for doctors in private practice. These recommendations are made available by doctors for doctors after prior review, analysis and daily updates. The new information platform recorded more than 15,000 hits in the first 24 hours.

The application deadline for the Bachelor Programme Health Sciences, which is the first part of the bologna-compliant medical studies programme, has been extended.

Researchers from the Karl Landsteiner University aim to develop a novel model of bone metastatic disease in breast cancer. A new project just launched aims at gaining insights into the development of bone metastases in breast cancer patients and identifying biomarkers as well as new treatment strategies.

Major worldwide research project discovers that 71% of women are unhappy with their breast size. The resulting reduced breast awareness might influence cancer detection by self-examination.

The second event of the Maimonides Lectures in Lower Austria "Psyche. Health, Disease and Healing in the Frame of Reference of the Abrahamic Religions", the 10th of the entire series of Maimonides Lectures scientifically led by Prof. Dr. Patrizia Giampieri-Deutsch and Prof. Dr. Hans-Dieter Klein, took place on Wednesday 27th and Thursday 28th November 2019 in the ballroom of the Karl Landsteiner Private University for Health Sciences in Krems an der Donau.

We would like to take this opportunity to say goodbye to you for the Christmas holidays.

A novel agent called Selinexor has opened up new options for the treatment of patients with refractory myeloma. This was the conclusion of a major international clinical trial in which also the Karl Landsteiner University of Health Sciences in Krems, Austria (KL Krems) participated. The results have now been published in the New England Journal of Medicine. Thanks to a new mode of action, the compound brings hope to the growing number of patients whose tumor cells have become resistant to the three backbone drug classes.

On Wednesday, 25.9.2019, a delegation of ACMIT - Austrian Center for Medical Innovation and Technology, honoured the Karl Landsteiner University of Health Sciences (KL) during a company outing.